These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2474282)

  • 1. Elevated levels of plasma lipofuscins in patients with chronic renal failure.
    Hegedus ZL; Frank HA; Steinman TI; Altschule MD; Nayak U
    Arch Int Physiol Biochim; 1988 Dec; 96(5):211-21. PubMed ID: 2474282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis of plasma soluble lipofuscins in patients with end-stage renal failure.
    Hegedus ZL; Frank HA; Steinman TI; Nayak U
    Arch Int Physiol Biochim Biophys; 1991 Aug; 99(4):355-63. PubMed ID: 1723328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of serum lipofuscin derived from 3-hydroxyanthranilic acid in patients with chronic renal failure.
    Hegedus ZL; Frank HA; Steinman TI; Altschule MD; Nayak U
    Arch Int Physiol Biochim; 1987 Dec; 95(5):457-63. PubMed ID: 2452619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma lipofuscin melanins formed from tryptophan metabolites.
    Hegedus ZL; Frank HA; Altschule MD; Nayak U
    Arch Int Physiol Biochim; 1986 Dec; 94(5):339-48. PubMed ID: 2440410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of melanin from human plasma lipofuscin.
    Hegedus ZL; Kuttab SH; Altschule MD; Nayak U
    Arch Int Physiol Biochim; 1981 Nov; 89(4):393-8. PubMed ID: 6174097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging.
    Hegedus ZL
    Toxicology; 2000 Apr; 145(2-3):85-101. PubMed ID: 10771134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative fluorescence intensities of human plasma soluble melanins in normal adults.
    Hegedus ZL; Nayak U
    Arch Int Physiol Biochim Biophys; 1994; 102(6):311-3. PubMed ID: 7894036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal excretion of plasma soluble melanins by healthy human adults.
    Hegedus ZL; Nayak U
    Arch Int Physiol Biochim Biophys; 1993; 101(6):417-23. PubMed ID: 7511438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in plasma lipofuscin levels of stored blood.
    Hegedus ZL; Altschule MD; Frank HA; Nayak U
    Crit Care Med; 1985 Mar; 13(3):155-9. PubMed ID: 3971724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on rheomelanins. VI. The apparent lipofuscin characteristics of rheomelanins.
    Hegedus ZL; Kuttab SH; Altschule MD
    Arch Int Physiol Biochim; 1980 Aug; 88(3):265-71. PubMed ID: 6159853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipofuscin products, lipid peroxides and aluminum accumulation in red blood cells of hemodialyzed patients.
    Jain SK; Abreo K; Duett J; Sella ML
    Am J Nephrol; 1995; 15(4):306-11. PubMed ID: 7573188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of pigmentation markers are elevated in patients undergoing hemodialysis.
    Murakami K; Wakamatsu K; Nakanishi Y; Takahashi H; Sugiyama S; Ito S
    Blood Purif; 2007; 25(5-6):483-9. PubMed ID: 18089933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum lipofuscin level after renal transplantation].
    Chmiel B; Kuśmierski S; Kokocińska D; Cierpka L
    Przegl Lek; 2003; 60(1):21-3. PubMed ID: 12884641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Para-aminophenol and structurally related compounds as intermediates in lipofuscin formation and in renal and other tissue toxicities.
    Hegedus ZL; Nayak U
    Arch Int Physiol Biochim Biophys; 1991 Feb; 99(1):99-105. PubMed ID: 1713494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of advanced glycation end products in children with renal disease.
    Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
    Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure.
    Totsune K; Takahashi K; Murakami O; Satoh F; Sone M; Mouri T
    Clin Sci (Lond); 1994 Sep; 87(3):319-22. PubMed ID: 7955908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure.
    Lang CC; Choy AM; Henderson IS; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Feb; 82(2):127-31. PubMed ID: 1311649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nile blue staining technic for the differentiation of melanin and lipofuscins.
    LILLIE RD
    Stain Technol; 1956 Jul; 31(4):151-3. PubMed ID: 13352041
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma 25-hydroxy-vitamin D in normal subjects and patients with terminal renal failure, on maintenance haemodialysis and after transplantation.
    Eastwood JB; Daly A; Carter GD; Alaghband-Zadeh J; De Wardener HE
    Clin Sci (Lond); 1979 Nov; 57(5):473-6. PubMed ID: 391471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of alpha-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis.
    Airaghi L; Garofalo L; Cutuli MG; Delgado R; Carlin A; Demitri MT; Badalamenti S; Graziani G; Lipton JM; Catania A
    Nephrol Dial Transplant; 2000 Aug; 15(8):1212-6. PubMed ID: 10910447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.